Brian Skorney
Stock Analyst at Robert W. Baird
(0.09)
# 4,323
Out of 4,386 analysts
849
Total ratings
34.9%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintained: Buy | $433 → $400 | $253.25 | +57.95% | 3 | Jun 2, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $38 → $36 | $18.24 | +97.37% | 15 | May 18, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $112 → $129 | $93.59 | +37.84% | 43 | May 7, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $209 → $252 | $232.04 | +8.60% | 2 | May 6, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $241 → $246 | $235.14 | +4.62% | 3 | May 5, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $63 → $97 | $51.21 | +89.42% | 6 | Mar 9, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Hold | $22 → $20 | $15.55 | +28.62% | 108 | Feb 26, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $108 → $145 | $128.10 | +13.19% | 81 | Feb 11, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $39 → $27 | $6.13 | +340.46% | 17 | Feb 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $637 → $742 | $611.34 | +21.37% | 63 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $250 | $192.62 | +29.79% | 97 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $33.48 | +85.19% | 16 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $52 | $11.12 | +367.63% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $186 | $163.12 | +14.03% | 52 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $32 | $16.81 | +90.36% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $18.99 | n/a | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $325 → $320 | $442.96 | n/a | 58 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $10.50 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $20 | $11.07 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $4.21 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.24 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $215 | $345.73 | n/a | 51 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $15.64 | n/a | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $4.40 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $0.5372 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $29.08 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $16.29 | n/a | 24 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $30.80 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $22.56 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $12.03 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $8.08 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $2.93 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 → $146 | $13.49 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $3.37 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $0.4701 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $144 | $51.36 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $270.80 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $94.17 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $56.55 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $22.33 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.63 | n/a | 3 | Jan 22, 2015 |
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $433 → $400
Current: $253.25
Upside: +57.95%
Alto Neuroscience
May 18, 2026
Maintained: Buy
Price Target: $38 → $36
Current: $18.24
Upside: +97.37%
Mirum Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $112 → $129
Current: $93.59
Upside: +37.84%
Jazz Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $209 → $252
Current: $232.04
Upside: +8.60%
Axsome Therapeutics
May 5, 2026
Maintained: Buy
Price Target: $241 → $246
Current: $235.14
Upside: +4.62%
Xenon Pharmaceuticals
Mar 9, 2026
Maintained: Buy
Price Target: $63 → $97
Current: $51.21
Upside: +89.42%
Sarepta Therapeutics
Feb 26, 2026
Maintained: Hold
Price Target: $22 → $20
Current: $15.55
Upside: +28.62%
Gilead Sciences
Feb 11, 2026
Maintained: Hold
Price Target: $108 → $145
Current: $128.10
Upside: +13.19%
REGENXBIO
Feb 10, 2026
Maintained: Buy
Price Target: $39 → $27
Current: $6.13
Upside: +340.46%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintained: Hold
Price Target: $637 → $742
Current: $611.34
Upside: +21.37%
Oct 31, 2025
Maintained: Buy
Price Target: $255 → $250
Current: $192.62
Upside: +29.79%
Sep 26, 2025
Maintained: Buy
Price Target: $62
Current: $33.48
Upside: +85.19%
Aug 12, 2025
Maintained: Buy
Price Target: $57 → $52
Current: $11.12
Upside: +367.63%
Jul 31, 2025
Maintained: Buy
Price Target: $180 → $186
Current: $163.12
Upside: +14.03%
Jun 18, 2025
Maintained: Buy
Price Target: $46 → $32
Current: $16.81
Upside: +90.36%
Feb 7, 2025
Maintained: Buy
Price Target: $25 → $17
Current: $18.99
Upside: n/a
Jan 31, 2025
Maintained: Sell
Price Target: $325 → $320
Current: $442.96
Upside: n/a
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $10.50
Upside: n/a
Nov 26, 2024
Maintained: Buy
Price Target: $26 → $20
Current: $11.07
Upside: n/a
Nov 20, 2024
Maintained: Buy
Price Target: $28
Current: $4.21
Upside: n/a
Nov 6, 2024
Maintained: Hold
Price Target: $4
Current: $4.24
Upside: n/a
Sep 24, 2024
Rated: Sell
Price Target: $215
Current: $345.73
Upside: n/a
Sep 5, 2024
Initiated Coverage: Buy
Price Target: $26
Current: $15.64
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $4.40
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $7.5
Current: $0.5372
Upside: n/a
Nov 10, 2022
Maintained: Buy
Price Target: $28
Current: $29.08
Upside: n/a
Nov 7, 2022
Maintained: Hold
Price Target: $8
Current: $16.29
Upside: n/a
Sep 8, 2022
Maintained: Hold
Price Target: $6
Current: $30.80
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $15
Current: $22.56
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $16
Current: $12.03
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $8.08
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $2.93
Upside: n/a
Aug 5, 2021
Maintained: Hold
Price Target: $85 → $146
Current: $13.49
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: $6
Current: $3.37
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: $7 → $3
Current: $0.4701
Upside: n/a
Mar 27, 2018
Maintained: Buy
Price Target: $144
Current: $51.36
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $270.80
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $94.17
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $56.55
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $22.33
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $4.63
Upside: n/a